Current Oncology Reports

, 5:274 | Cite as

Recent advances in radiotherapy for soft-tissue sarcoma

  • Brian O’sullivan
  • Iain Ward
  • Charles Catton

Abstract

The use of radiotherapy in soft-tissue sarcoma continues to evolve. This review focuses on how current management is influenced by the most recent publications in the field. In particular, experience of patients treated without radiotherapy permits guidelines to be established that define a subset of patients who do not need radiotherapy to achieve sarcoma cure with good function. Strategies for radiotherapy delivery are discussed, including the most recent prospective results from a trial of preoperative and postoperative radiotherapy, with particular emphasis on randomized data. Also, the definitions for adequacy of surgical excision and the ability to achieve high rates of local control when margins are minimally positive are integrated into a planned approach. The difficult problem of retroperitoneal sarcoma is discussed, as are chemoradiotherapy protocols that may enhance local and systemic outcome. Finally, the potential for image-guided radiotherapy, enhanced targeting, and better radiotherapy delivery in the contemporary era is addressed.

References and Recommended Reading

  1. 1.
    Choong PF, Petersen IA, Nascimento AG, Sim FH: Is radiotherapy important for low-grade soft tissue sarcoma of the extremity? Clin Orthop 2001, 387:191–199.PubMedCrossRefGoogle Scholar
  2. 2.
    O’sullivan B, Bell RS, Bramwell VHC: Sarcomas of the soft tissues. In Oxford Textbook of Oncology, edn 2. Edited by Souhami RL, Tannock I, Hohenberger P, Horiot J-C. Oxford: Oxford University Press; 2002:2495–2523. A multimodality, evidence-based discussion of the management of soft-tissue sarcoma that addresses different disease areas and situations.Google Scholar
  3. 3.
    Mollabashy A, Virkus WW, Zlotecki RA, et al.: Radiation therapy for low-grade soft tissue sarcoma. Clin Orthop 2002, 397:190–195.PubMedCrossRefGoogle Scholar
  4. 4.
    Alektiar KM, Leung D, Zelefsky MJ, Brennan MF: Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity. J Clin Oncol 2002, 20:1643–1650.PubMedCrossRefGoogle Scholar
  5. 5.
    Alektiar KM: Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity [letter reply]. J Clin Oncol 2002, 20:3930.CrossRefGoogle Scholar
  6. 6.
    Henshaw RM, Priebat DA, Perry DJ, et al.: Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary? Ann Surg Oncol 2001, 8:484–495.PubMedCrossRefGoogle Scholar
  7. 7.
    Brennan MF: More is less: systemic treatment for local control in soft tissue sarcoma. Ann Surg Oncol 2001, 8:480–481.PubMedCrossRefGoogle Scholar
  8. 8.
    O’sullivan B, Bell RS. Has ‘MAID’ made it in the management of high-risk soft tissue sarcoma? Int J Radiat Oncol Biol Phys, in press.Google Scholar
  9. 9.
    O’sullivan B, Davis AM, Turcotte R, et al.: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002, 359:2235–2241. The first prospective, randomized trial to address the controversy underlying the choice of preoperative versus postoperative radiotherapy in extremity soft-tissue sarcoma. This trial is only the fourth randomized trial to evaluate local management in this group of patients. It is both the largest and the only multicenter study.PubMedCrossRefGoogle Scholar
  10. 10.
    ICRU Report 62: Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). Bethesda, MD: International Commission on Radiation Units and Measurement; 1999.Google Scholar
  11. 11.
    Wayne JD, Langstein HN, Pollack A, et al.: Preoperative radiotherapy for extremity soft tissue sarcoma (STS): site specific wound complication rates and the impact of reconstructive surgery [abstract]. Proc ASCO 2000, 19:558a.Google Scholar
  12. 12.
    O’sullivan B, Davis AM: A randomized phase III trial of preoperative compared to post-operative radiotherapy in extremity soft tissue sarcoma. Proc American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 2001, 51(Suppl 1):151–152.CrossRefGoogle Scholar
  13. 13.
    Davis AM, O’sullivan B, Bell RS, et al.: Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 2002, 20:4472–4477. A unique health-related quality-of-life and function assessment paper that accompanies O’sullivan et al. [9]. These endpoints are addressed prospectively in this randomized trial.PubMedCrossRefGoogle Scholar
  14. 14.
    Vaidya JS, Palazzo FF: Radiotherapy in soft-tissue sarcoma [letter]. Lancet 2002, 360:1989.PubMedCrossRefGoogle Scholar
  15. 15.
    Hartford AC, Gohongi T, Fukumura D, Jain RK: Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res 2000, 60:2128–2131.PubMedGoogle Scholar
  16. 16.
    O’sullivan B, Bell R, Davis A, et al.: Radiotherapy in soft-tissue sarcoma [letter reply]. Lancet 2002, 360:1989.CrossRefGoogle Scholar
  17. 17.
    Pisters PWT, O’sullivan B, Pollock RE: Soft tissue sarcoma. In Prognostic Factors in Cancer, edn 2. Edited by Gospodarowicz MK, Henson DE, Hutter RVP, et al.: New York: Wiley-Liss; 2002:415–433.Google Scholar
  18. 18.
    Karakousis CP, Zografos GC: Radiation therapy for high grade soft tissue sarcomas of the extremities treated with limb-preserving surgery. Eur J Surg Oncol 2002, 28:431–436. Important contribution because the results clarify the issue of local control for a given benchmark width of resection margin. The authors acknowledge that the indications for radiotherapy could be broadened to treat patients with wider margins as well, thereby potentially lowering the local failure rate further.PubMedCrossRefGoogle Scholar
  19. 19.
    Gerrand CH, Wunder JS, Kandel RA, et al.: Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br 2001, 83:1149–1155. The first paper to emphasize the cause of positive resection margins and correlate these prognostic factors with outcome in a large patient cohort.PubMedCrossRefGoogle Scholar
  20. 20.
    Virkus WW, Marshall D, Enneking WF, Scarborough MT: The effect of contaminated surgical margins revisited. Clin Orthop 2002, 397:89–94.PubMedCrossRefGoogle Scholar
  21. 21.
    Pisters PW, O’sullivan B: Retroperitoneal sarcomas: combined modality treatment approaches. Curr Opin Oncol 2002, 14:400–405.PubMedCrossRefGoogle Scholar
  22. 22.
    Nielsen OS, O’sullivan B: Retroperitoneal soft tissue sarcomas: a treatment challenge and a call for randomized trials. Radiother Oncol 2002, 65:133–136.PubMedCrossRefGoogle Scholar
  23. 23.
    Youssef E, Fontanesi J, Mott M, et al.: Long-term outcome of combined modality therapy in retroperitoneal and deeptrunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys 2002, 54:514–519.PubMedCrossRefGoogle Scholar
  24. 24.
    Brennan MF: Retroperitoneal sarcoma: time for a national trial? Ann Surg Oncol 2002, 9:324–325.PubMedGoogle Scholar
  25. 25.
    Jones JJ, Catton CN, O’sullivan B, et al.: Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol 2002, 9:346–354. Prospective pilot trial of preoperative radiotherapy, surgery, and postoperative brachytherapy from the Princess Margaret Hospital in Toronto. The study had the unique advantage that toxicity of preoperative radiotherapy was separated prospectively from that of postoperative brachytherapy. Preoperative radiotherapy had a low toxicity profile notwithstanding the large field sizes.PubMedGoogle Scholar
  26. 26.
    van Dalen T, Hoekstra HJ, van Geel AN, et al.: Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol 2001, 27:564–568.PubMedCrossRefGoogle Scholar
  27. 27.
    Stoeckle E, Coindre JM, Bonvalot S, et al.: Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001, 92:359–368. This report of a large series of patients from the French Cancer Center Federation Sarcoma Group shows outcome differences potentially due to the use of postoperative radiotherapy in the management of retroperitoneal sarcoma. The retrospective nature of the data makes it difficult to resolve problems of selection bias, and the authors suggest that a randomized trial is necessary.PubMedCrossRefGoogle Scholar
  28. 28.
    Gilbeau L, Kantor G, Stoeckle E, et al.: Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol 2002, 65:137–143.PubMedCrossRefGoogle Scholar
  29. 29.
    Gieschen HL, Spiro IJ, Suit HD, et al.: Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2001, 50:127–131. Long term follow-up from the Massachusetts General Hospital on a series of patients with retroperitoneal sarcoma treated with preoperative radiotherapy, surgery, and IORT.PubMedCrossRefGoogle Scholar
  30. 30.
    Petersen IA, Haddock MG, Donohue JH, et al.: Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2002, 52:469–475. The Mayo Clinic experience with preoperative radiotherapy and IORT in retroperitoneal sarcoma.PubMedCrossRefGoogle Scholar
  31. 31.
    Cormier JN, Patel SR, Herzog CE, et al.: Concurrent ifosfamide-based chemotherapy and irradiation: analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer 2001, 92):1550–1555.CrossRefGoogle Scholar
  32. 32.
    Pisters PW, Ballo MT, Patel SR: Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol 2002, 9:535–542.PubMedCrossRefGoogle Scholar
  33. 33.
    Lartigau E, Kantor G, Taieb S, et al.: Definitions of target volumes in soft tissue sarcomas of the extremities [in French]. Cancer Radiother 2001, 5:695–703. A description of target volume delineation for radiotherapy of soft-tissue sarcoma in the era of magnetic resonance. An equivalent English version would be beneficial for more widespread readership.PubMedGoogle Scholar
  34. 34.
    Hong L, Alektiar K, Chui C, et al.: IMRT of large fields: wholeabdomen irradiation. Int J Radiat Oncol Biol Phys 2002, 54:278–89. This paper from the Memorial-Sloan Kettering group highlights the technical challenges and opportunities provided by IMRT in treating complex large volumes with avoidance of critical structures, as is often needed in treatment of intra-abdominal sarcomas.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2003

Authors and Affiliations

  • Brian O’sullivan
    • 1
  • Iain Ward
    • 1
  • Charles Catton
    • 1
  1. 1.Department of Radiation Oncology, Princess Margaret HospitalUniversity of TorontoTorontoCanada

Personalised recommendations